PSYC Stock Overview
A health supplements company, produces and distributes mushroom-derived products and related consumer packaged goods in Canada.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Psyched Wellness Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.08 |
52 Week High | CA$0.10 |
52 Week Low | CA$0.03 |
Beta | 2.79 |
1 Month Change | 23.08% |
3 Month Change | 100.00% |
1 Year Change | -20.00% |
3 Year Change | -73.33% |
5 Year Change | n/a |
Change since IPO | -44.83% |
Recent News & Updates
Shareholder Returns
PSYC | CA Personal Products | CA Market | |
---|---|---|---|
7D | -20.0% | -0.2% | -1.2% |
1Y | -20.0% | -8.0% | 10.5% |
Return vs Industry: PSYC underperformed the Canadian Personal Products industry which returned -8% over the past year.
Return vs Market: PSYC underperformed the Canadian Market which returned 10.5% over the past year.
Price Volatility
PSYC volatility | |
---|---|
PSYC Average Weekly Movement | 22.2% |
Personal Products Industry Average Movement | 9.4% |
Market Average Movement | 8.8% |
10% most volatile stocks in CA Market | 17.4% |
10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: PSYC's share price has been volatile over the past 3 months.
Volatility Over Time: PSYC's weekly volatility (22%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Jeff Stevens | psyched-wellness.com |
Psyched Wellness Ltd., a health supplements company, produces and distributes mushroom-derived products and related consumer packaged goods in Canada. The company offers a line of Amanita Muscaria-derived water-based extracts, teas, and capsules to promote stress relief, relaxation, and assist with restful sleeping. It sells its products online.
Psyched Wellness Ltd. Fundamentals Summary
PSYC fundamental statistics | |
---|---|
Market cap | CA$22.81m |
Earnings (TTM) | -CA$3.11m |
Revenue (TTM) | CA$326.00k |
70.0x
P/S Ratio-7.3x
P/E RatioIs PSYC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PSYC income statement (TTM) | |
---|---|
Revenue | CA$326.00k |
Cost of Revenue | CA$157.21k |
Gross Profit | CA$168.80k |
Other Expenses | CA$3.28m |
Earnings | -CA$3.11m |
Last Reported Earnings
Feb 29, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.011 |
Gross Margin | 51.78% |
Net Profit Margin | -953.91% |
Debt/Equity Ratio | 0% |
How did PSYC perform over the long term?
See historical performance and comparison